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Abstract
Objectives
To evaluate hepatic fat fraction on dual- and triple-echo gradient-recalled echo MRI se-
quences in healthy children.
Materials and Methods
We retrospectively reviewed the records of children in a medical check-up clinic from
May 2012 to November 2013. We excluded children with abnormal laboratory findings or
those who were overweight. Hepatic fat fraction was measured on dual- and triple-echo se-
quences using 3T MRI. We compared fat fractions using the Wilcoxon signed rank test
and the Bland-Altman 95% limits of agreement. The correlation between fat fractions and
clinical and laboratory findings was evaluated using Spearman’s correlation test, and the
cut-off values of fat fractions for diagnosing fatty liver were obtained from
reference intervals.
Results
In 54 children (M:F = 26:28; 5–15 years; mean 9 years), the dual fat fraction (0.1–8.0%; me-
dian 1.6%) was not different from the triple fat fraction (0.4–6.5%; median 2.7%) (p = 0.010).
The dual- and triple-echo fat fractions showed good agreement using a Bland-Altman plot
(-0.6 ± 2.8%). Eight children (14.8%) on dual-echo sequences and six (11.1%) on triple-
echo sequences had greater than 5% fat fraction. From these children, six out of eight chil-
dren on dual-echo sequences and four out of six children on triple-echo sequences had a
5–6% hepatic fat fraction. When using a cut-off value of a 6% fat fraction derived from a ref-
erence interval, only 3.7% of children were diagnosed with fatty liver. There was no signifi-
cant correlation between clinical and laboratory findings with dual and triple-echo
fat fractions.
PLOS ONE | DOI:10.1371/journal.pone.0117480 February 6, 2015 1 / 10
OPEN ACCESS
Citation: Shin HJ, Kim HG, Kim M-J, Koh H, Kim HY,
Roh YH, et al. (2015) Normal Range of Hepatic Fat
Fraction on Dual- and Triple-Echo Fat Quantification
MR in Children. PLoS ONE 10(2): e0117480.
doi:10.1371/journal.pone.0117480
Academic Editor: Vincent Wong, The Chinese
University of Hong Kong, HONG KONG
Received: September 2, 2014
Accepted: December 23, 2014
Published: February 6, 2015
Copyright: © 2015 Shin et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This study was supported by a new faculty
research seed money grant of Yonsei University
College of Medicine for 2013 (8-2013-0028). The
funder had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Conclusions
Dual fat fraction was not different from triple fat fraction. We suggest a cut-off value of a 6%
fat fraction is more appropriate for diagnosing fatty liver on both dual- and triple-echo se-
quences in children.
Introduction
Fatty liver is a spectrum of conditions in which hepatocyte triglycerides are increased [1]. In
the United States, the prevalence of fatty liver is 25–35% for the general population and 80–
90% for obese patients (body mass index [BMI])> 30 kg/m2), [1,2]. In particular, nonalcoholic
fatty liver disease (NAFLD) is increasing in children, affecting approximately 3–17% of Ameri-
can children and 38% of overweight or obese children [3,4]. NAFLD includes a wide spectrum
of conditions, ranging from simple steatosis to nonalcoholic steatohepatitis, which can progress
to cirrhosis [3,5]. Obesity is the most common cause of fatty liver. However, many other condi-
tions such as drugs, storage diseases, chronic viral infections, toxins, and others can lead to
fatty change of the liver [1,6]. An early diagnosis of fatty liver can prevent more serious compli-
cations by initiating early treatment. This is especially important as fatty liver can be reversed
to a normal range if appropriate and prompt corrections are implemented [3,7]. Therefore,
early detection of fatty liver and quantification of hepatic fat can be meaningful in many ways.
Ultrasonography can be a useful and easy diagnostic method for detecting fatty liver without
any radiation exposure. Although one study attempted to quantitatively analyze hepatic steato-
sis with ultrasonography [8], available evidence does not support the use of ultrasonography
for the diagnosis or grading of fatty liver in children [1,9]. Computed tomography (CT) can de-
tect fat infiltration in the liver by analyzing the attenuation of the liver parenchyma; however,
the risk of radiation exposure is a major disadvantage, especially in pediatric patients. In addi-
tion, various hepatic conditions such as cirrhosis and inflammation can influence the density
of liver parenchyma on CT images [1]. Liver parenchyma biopsy is the gold standard for diag-
nosing fatty liver. However, this procedure only obtains a small portion of the liver, which can
cause sampling bias in addition to being an invasive method requiring sedation in young chil-
dren [10].
Magnetic resonance imaging (MRI) can detect hepatic fat infiltration simply and accurately.
Proton magnetic resonance spectroscopy (MRS) makes it possible to quantitatively measure
even small amount of fat content in the liver [1,7]; however, parameter setting and post-
processing techniques are not easy [11]. Quantitative measurement of fat fraction using a
chemical shift technique, which distinguishes the differences of resonant frequencies between
fat and water, can be an easy way to evaluate fat in the liver [12]. It can be obtained using dual-
or triple-echo gradient-recalled echo sequences and is not influenced by underlying hepatic
conditions such as fibrosis, even in children [5]. These sequences are easy to perform with any
scanner from a variety of vendors in a relatively short time.
Fatty liver can be diagnosed histopathologically if the percentage of triglyceride content ex-
ceeds 5%, according to the Nonalcoholic Steatohepatitis Clinical Research Network scoring
system [13,14]. Previous studies demonstrated that the normal hepatic fat content using fat
quantification MRI was less than 5% in adults [1,15]; however, the normal range of hepatic fat
fraction using dual- and triple-echo sequences in children is not yet defined to our knowledge.
Therefore, the purpose of this study was to evaluate the normal ranges of hepatic fat fraction
on dual- and triple-echo gradient recalled-echo sequences of MRI in healthy children, and
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suggest a cut-off value for diagnosing fatty liver on both dual- and triple-echo sequences
in children.
Materials and Methods
Subjects characteristics
The Institutional Review Board of Severance Hospital approved this retrospective study and re-
quired neither patient approval nor informed consent for review of patients’ images and medi-
cal records. The abdominal MRI examination was routinely performed in the medical check-
up clinic at our tertiary hospital, as well as laboratory tests. We reviewed the medical records of
children who visited our medical check-up clinic fromMay 2012 to November 2013. Age, sex,
height, weight, BMI, and routine laboratory findings, including liver function tests (aspartate
aminotransferase [AST], alanine aminotransferase [ALT]), glucose, cholesterol, albumin, alka-
line phosphatase (ALP), total bilirubin, triglycerides, and ferritin levels, obtained on the same
day as abdominal MRI examination were reviewed.
We excluded children with abnormal laboratory findings or those who were overweight
(BMI greater than 25 kg/m2), which can influence hepatic fat infiltration. Abnormal laboratory
levels included a serum AST level greater than 34 IU/L, ALT greater than 46 IU/L, glucose
greater than 110 mg/dL, cholesterol greater than 220 mg/dL, albumin greater than 5.4 g/dL,
ALP greater than 341 IU/L, total bilirubin greater than 1.2 mg/dL, triglycerides greater than
166 mg/dL, and ferritin greater than 336.2 ng/mL.
MRI acquisition and image analysis
Hepatic fat fraction (%) was measured on dual- and triple-echo gradient-recalledecho se-
quences of a routine check-up abdominal MR protocol performed on a 3T MR system (Tim
Trio; Siemens Medical Solutions, Erlangen, Germany) with a body coil.
For dual-echo chemical-shift gradient-echo MRI (DE-MRI), we obtained axial images of the
liver using gradient echo T1-weighted, dual-echo, in-phase and opposed-phase sequences (TR,
226 msec; TE, 1.23 [opposed-phase] /2.46 [in-phase] msec; flip angle, 65°; section thickness,
6 mm; matrix size, 192×256; acquisition time, 14 sec; and field of view, 300×400 cm). For tri-
ple-echo MRI (TE-MRI), the imaging protocol included a breath-hold low-flip-angle T1-
weighted, triple-echo, spoiled gradient-echo sequence (TR 226 msec; TE 2.46 [in-phase 1]/3.69
[opposed-phase] /4.92 [in-phase 2] msec; flip angle, 20°; section thickness, 6 mm; matrix size,
256 × 192; acquisition time, 19 sec; and field of view, 315×420 cm).
One radiologist (M.J.L.) with 10 years of experience in pediatric radiology randomly drew
three regions of interest (ROIs) in each image of homogenous parenchyma of the right hepatic
lobe avoiding hepatic vessels on a picture archiving and communication system (Centricity,
General Electric Corporation, Milwaukee, WI) and used the mean value of the three signal in-
tensities. The reviewer was blinded to the demographics and clinical and laboratory data of the
children at the time of image analysis. The signal intensities were obtained by drawing ROIs at
the same location of the liver in both in-phase (IP) and opposed-phase (OP) images. The he-
patic fat fraction in DE-MRI was calculated from the equation as follows: dual-echo fat fraction
(%) = [(IP-OP)/(2 × IP)] × 100 [7].
Theoretically, three mean values of the signal intensities should be obtained for measuring
the triple-echo fat fraction in all of the in-phase 1 (IP1), opposed-phase (OP), and in-phase 2
(IP2) images. The hepatic fat fraction in TE-MRI can be calculated from the equation as fol-
lows: triple-echo fat fraction (%) = [{(IP1+IP2)/2—OP}/(IP1+IP2)] × 100 [11]. In our worksta-
tion, the triple-echo fat fraction was automatically calculated and we obtained a triple-echo fat
map for direct fat fraction measurement by drawing ROIs in this map.
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Statistical analysis
TheWilcoxon signed rank test was used to compare dual- and triple-echo fat fractions after
testing for normality. Bland-Altman 95% limits of agreement were used to evaluate the agree-
ment among dual- and triple-echo fat fractions. The Bland-Altman plot was represented by as-
signing the mean of the dual- and triple-echo fat fractions as the x-axis value and the difference
between these two values as the y-axis value. Spearman’s correlation test was used to evaluate
the correlation between fat fraction and clinical or laboratory findings. Among the laboratory
findings, we evaluated the correlation with serum glucose, cholesterol levels, and triglyceride
levels according to previous studies [5,16,17]. P values< 0.05 were considered statistically sig-
nificant for all analyses. Analysis was performed using SPSS version 20.0.0 (IBM Corp.,
Armonk, NY, USA). The software R version 3.0.1 (The R Foundation for Statistical Comput-
ing, Vienna, Austria) was also used for the evaluation of cut-off values of fat fractions using the
reference interval and confidence interval, which refer to the variation of the measurements in
healthy individuals according to the previously reported guidelines [18].
Results
Clinical and laboratory findings
During the study period, a total of 72 children ranging from 5 to 16 years old visited our medi-
cal check-up clinic. Among these children, 18 were excluded due to abnormal laboratory find-
ings in 17 children, overweight body habitus in 5 children, and both problems in 4 children. In
total, 54 children were enrolled in this study, including 26 boys and 28 girls. The age range
was 5–15 years with a mean of 9 years. The mean height was 133.9 ± 17.3 cm with a range of
108–178 cm. The mean weight was 32.0 ±12.4 kg with a range of 16–65 kg. The mean BMI was
17.2 ± 3.0 kg/m2 with a range of 12.2–24.3kg/m2.
On laboratory findings, the mean AST level was 22.2 ± 4.5 IU/L with a range of 12–32 IU/L
and the mean ALT level was 12.2 ± 6.3 IU/L with a range of 6–45 IU/L. The mean glucose level
was 90.6 ± 6.5 mg/dL with a range of 74–108 mg/dL. The mean cholesterol level was 167.5 ±
19.6 mg/dL with a range of 122–206 mg/dL. The mean albumin level was 4.5 ± 0.2 g/dL with a
range of 4–5 g/dL. The mean ALP level was 180.0 ± 54.9 IU/L with a range of 56–335 IU/L,
and the mean total bilirubin level was 0.6 ± 0.2 mg/dL with a range of 0.2–1.2 mg/dL. The
mean triglyceride level was 68.5 ± 24.8 mg/dL with a range of 36–148 mg/dL, and the mean fer-
ritin level was 34.9 ± 20.3 ng/mL with a range of 12–111.6 ng/mL.
Fat fraction on MR
The median dual-echo fat fraction was 1.6% with a range of 0.1–8.0%, and the median triple-
echo fat fraction was 2.7% with a range of 0.4–6.5%. The value of the dual-echo fat fraction was
not significantly different from that of the triple-echo (p = 0.010) (Fig. 1). The Bland-Altman
95% limits of agreement were-3.4% to 2.2% for the difference between dual-echo and triple-
echo fat fractions, compared with mean value of these two fat fractions (Fig. 2). In the Bland-
Altman plot, all of the values were included within the range of 1.96 standard deviations of the
difference, indicating significant agreement between dual and triple-echo fat fractions. There
was also a tendency of differences concentrated below the mean value of-0.6% in small fat frac-
tions (<3% fat fractions). This result implied that the triple-echo fat fraction tend to increase
more than the dual-echo fat fraction when the fat fractions were small, 3% or less.
The results of the correlation analysis between clinical and laboratory findings and the he-
patic fat fraction on DE- and TE-MRI are summarized in Table 1. There was no significant cor-
relation between clinical and laboratory findings with dual- and triple-echo fat fractions. The
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serum triglyceride level and BMI showed a positive correlation with hepatic fat fraction with-
out statistical significance. The serum cholesterol level showed a negative correlation on DE-
MRI, while it had a positive correlation on TE-MRI, although neither correlation was
statistically significant.
The reference intervals were 5.9% (confidence interval 4.7–7.2) for DE-MRI and 5.6%
(confidence interval 4.6–6.7) for TE-MRI. When using a known cut-off value of 5% fat frac-
tion for fatty liver evaluation, eight children (8 of 54, 14.8%) on DE-MRI and six children
(6 of 54, 11.1%) on TE-MRI showed a greater than 5% fat fraction, which can lead to a false
positive diagnosis. Among the eight children with a greater than a 5% fat fraction on DE-MRI,
six children had a 5–6% hepatic fat fraction and the remaining two had a 7–8% hepatic fat
fraction. On TE-MRI, four out of six children had a 5–6% hepatic fat fraction, and two chil-
dren had a 6–7% hepatic fat fraction. There were fewer healthy children who had more than a
6% fat fraction on both DE- and TE-MRI, than those who were above the 5% cut-off value.
When we applied the cut-off value of a 6% fat fraction, as the nearest whole number from
the reference interval, the false positive rate decreased to 3.7% (2 of 54) for both DE- and
TE-MRI.
Fig 1. Comparison of hepatic fat fraction (%) in dual- and triple-echo MRI. The dual-echo fat fraction
(mean 2.3 ± 2.0%) was not different from the triple-echo fat fraction (mean 2.9 ± 1.4%) in healthy children
(p = 0.010).
doi:10.1371/journal.pone.0117480.g001
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Discussion
Prior studies have revealed that NAFLD is not an uncommon problem in children, with an es-
timated incidence of approximately 3–17% in American children and 38% in overweight and
Fig 2. Bland-Altman plots for measurement of hepatic fat fraction using dual and triple-echo MRI. Bland-Altman plots demonstrated good agreement
between dual and triple-echo fat fractions.
doi:10.1371/journal.pone.0117480.g002
Table 1. Correlation between clinical and laboratory ﬁndings and hepatic fat fraction in dual- and triple-echo fat quantiﬁcation MRI.
Parameters Dual-echo fat fraction Triple-echo fat fraction
r P value* r P value*
Age (years) -0.097 0.485 -0.087 0.530
Height (cm) -0.128 0.355 -0.115 0.409
Weight (kg) -0.009 0.951 -0.006 0.968
Body mass index (kg/m2) 0.195 0.159 0.206 0.136
Glucose (mg/dL) -0.163 0.238 -0.155 0.262
Cholesterol (mg/dL) -0.085 0.541 0.051 0.717
Triglycerides (mg/dL) 0.189 0.171 0.081 0.561
*from Spearman’s correlation test
doi:10.1371/journal.pone.0117480.t001
Hepatic Fat Fraction in Healthy Children
PLOS ONE | DOI:10.1371/journal.pone.0117480 February 6, 2015 6 / 10
obese children [3,4,19]. Beyond its high prevalence, NAFLD is important as it can lead to
more serious problems such as hepatic cirrhosis or hepatocellular carcinoma [3,19]. In addi-
tion, it can accompany metabolic syndrome, cardiovascular disease, or diabetes mellitus; how-
ever, it is reversible with early correction [3,19]. Therefore the early, accurate, and
quantitative diagnosis of fatty change of the liver has very important clinical implications, es-
pecially for children.
Although the gold standard for diagnosis remains liver biopsy, this invasive procedure is
not feasible in daily clinical practice and can raise ethical issues, especially when performed for
screening healthy children for fatty liver disease. Therefore, recent studies have dedicated ef-
forts to diagnosing fatty liver using ultrasound, CT, and MRI, including MRS. From these, DE-
MRI has been used for a long time given its advantage of quantifying the hepatic fat fraction in
the entire liver non-invasively [15,20,21]. Moreover, TE-MRI has improved the measurement
of hepatic fat content by allowing a simple correction for T2 decay [11].
In previous reports, fatty change of the liver was defined as a greater than 5% accumulation
of triglycerides in hepatocytes on histopathologic analysis [13,14]. It is well known that fat
quantification MRI shows a strong correlation with hepatic steatosis level, especially in the as-
sessment of macrovesicular steatosis, which is a common form of steatosis in NAFLD [5,22]. A
recent study revealed that a cut-off value of 6.9% on triple-echo fat fraction MRI provided 93%
sensitivity and 100% specificity in diagnosing hepatic steatosis in an adult population [23];
however, few studies on the normal hepatic fat fraction have been conducted in children. Fish-
bein et al. [24] applied a cut-off value of 9% to evaluate fatty liver in children using their previ-
ous results, using a value of greater than 2 standard deviations above the mean hepatic fat
fraction of healthy adults. It is crucial to recognize the possibility of a difference between the
normal ranges of hepatic fat fraction of children and adults on MRI. There was only one report
that investigated the normal hepatic fat fraction in children. In 2011, Pacifico et al. [5] sug-
gested a cut-off value of 4.85% for the diagnosis of fatty liver in children on MRI using a modi-
fication of the Dixon method; however, the standard hepatic fat fraction value in healthy
children on DE- and TE-MRI is not yet well known, even though it is a basic sequence in al-
most all MRI machines.
Our study revealed the normal hepatic fat fraction ranges on DE-MRI (0.1–8.0%) and TE-
MRI (0.4–6.5%) with a median value of 1.6% on DE-MRI and 2.7% on TE-MRI, and fat frac-
tions using DE- and TE-MRI showed good agreement using Bland Altman plot. When we used
a cut-off value of 5% for diagnosing hepatic steatosis, which is widely accepted as the normal
range of hepatic fat fraction in histopathology, 14.8% of children (8 of 54) on DE-MRI and
11.1% of children (6 of 54) on TE-MRI had a greater than 5% fat fraction, which can result in
false positive diagnosis. When we used a cut-off value of 6% for diagnosing hepatic steatosis,
according to the reference interval, the false positive rate decreased to 3.7% (2 of 54) on both
DE- and TE-MRI. Therefore, we suggest a cut-off value of 6% is more appropriate for children
to diagnose fatty liver disease on both DE- and TE-MRI.
Our study also demonstrated that the triple-echo fat fraction showed a relatively narrow
range (range 0.4–6.5%; median 2.7%) than the dual-echo fat fraction (range 0.1–8.0%; median
1.6%); however, we could not demonstrate a statistical difference in range. These results may
be due to the high accuracy of TE-MRI for diagnosing fat fraction by minimizing the effect of
iron deposition or inflammation from hepatitis, NAFLD, cirrhosis or hemochromatosis, as
previously reported [11,25]. TE-MRI could reduce the susceptibility effect of iron by reducing
T2 decay using a corrected IP, while the confounding T2 and T2 effect could result in uncor-
rected fat quantification on DE-MRI [7,26]. However, our study included only healthy chil-
dren, and we cannot be sure of the effect of iron deposition in normal liver. Further studies
regarding the accuracy of TE-MRI in pediatric liver disease are required.
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In the analysis of correlation between the hepatic fat fraction on MR and clinical and labora-
tory findings, there was no significant correlation between clinical and laboratory findings with
fat fractions. Previous reports suggested significant correlations between fat fraction on DE-
and TE-MRI with BMI, gender, glucose, cholesterol, and triglyceride levels [5,16,17]. In a re-
cent study of a pediatric cohort, Lee et al. [27] also revealed a strong correlation of hepatic stea-
tosis and clinical data in pediatric patients. This difference could be from the different subject
group of our study, as we included only healthy children. Lee et al. [27] explained that pediatric
patients showed a stronger correlation of hepatic steatosis with clinical data than adults, due to
low exposure to comorbidities and medication usage in children. Additional studies including
not only healthy children but also pediatric fatty liver disease patients and overweight children
are needed to evaluate the usefulness of DE- and TE-MRI in monitoring triglyceride level and
detecting fatty liver more sensitively.
Our study has several limitations. First, we did not obtain histopathologic results of the
liver as a reference standard. We presumed that children with normal ranges of clinical and
laboratory parameters would have a normal hepatic fat fraction. Moreover, we did not per-
form follow-up in these children. Routine follow-up was not recommended in healthy chil-
dren. However, there is a possibility of hidden hepatic disease in the enrolled children, and
even liver biopsy also has limitations in evaluating diffuse liver disease, due to the heterogene-
ity of disease distribution in the liver [28]. Second, the number of included children was also
small, given that abdominal MRI is not a commonly performed study during pediatric health
maintenance visits. Additional studies with a large number of children and more concrete ref-
erence standards are required. The third limitation is that the image analysis using the region
of interest was not obtained from the whole liver on both DE- and TE-MRI. This could affect
the results of hepatic fat fraction depending on the position of the ROI. However, the mea-
surement of ROI in the whole liver could result in an inaccurate fat fraction by including
other anatomic structures such as vessels and bile ducts. The respiratory motion artifact in the
liver dome as well as the partial volume effect also could affect the accuracy of the data. There-
fore, we attempted to measure fat fraction using three ROIs in each image in the homogeneous
parenchyma avoiding artifacts and vascular structures, as a representation of the whole liver
in children.
In conclusion, the median value of the normal hepatic fat fraction was 1.6% (range 0.1–
8.0%) on dual-echo sequences and 2.7% (range 0.4–6.5%) on triple-echo sequences with no dif-
ferences among healthy children. We suggest a cut-off value of 6% fat fraction is more appro-
priate for diagnosing fatty liver on both dual- and triple-echo sequences as it can lower the
false positive rate to 3.7% in children.
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